We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI-Based Scoring of Lymphocytes Outperforms Traditional Pathologist Eyeballing

By LabMedica International staff writers
Posted on 22 Jul 2025

Melanoma is a type of skin cancer where tracking tumor-infiltrating lymphocytes plays a critical role in assessing the body’s immune response and predicting patient outcomes. More...

Traditionally, pathologists evaluate these immune cells visually under a microscope—a process known as "eyeballing" which is subjective and prone to variability. This lack of standardization can affect the accuracy of diagnoses and treatment decisions. As more tumor-infiltrating lymphocytes are linked with better patient outcomes, ensuring reliable assessments is crucial for guiding clinical care. Now, researchers have tested a new artificial intelligence (AI)-based method that provides a more consistent and reproducible approach to lymphocyte quantification, significantly outperforming conventional visual assessment.

In a study involving 45 institutions globally, researchers at Yale School of Medicine (New Haven, CT, USA) and Karolinska Institute (Stockholm, Sweden) led the development of an open-source AI tool designed to quantify tumor-infiltrating lymphocytes in melanoma tissue. The research team used a dataset of 60 melanoma samples, with 98 participants performing quantification. Of these, 40 were pathologists using traditional visual scoring, while 11 pathologists and 47 non-pathologist scientists used the AI tool. This open-source algorithm processes digitized pathology images and automates lymphocyte counting, reducing variability and offering a standardized method suitable for integration into clinical workflows.

In the study, published in JAMA Network Open, the AI tool showed superior reproducibility compared to traditional methods. The results confirm that AI-based quantification offers a robust, reliable alternative for assessing tumor-infiltrating lymphocytes. Although the retrospective design limits immediate clinical application, the publicly available dataset and algorithm provide a strong foundation for further validation. Researchers plan to continue refining the tool and integrating it into routine melanoma management, ultimately enhancing diagnostic accuracy and treatment personalization.

"Our findings suggest that an AI-driven lymphocyte quantification tool may provide consistent, reliable assessments with a strong potential for clinical use, offering a robust alternative to traditional methods," said Thazin Nwe Aung, PhD, lead author of the study.

Related Links:
Yale School of Medicine
Karolinska Institute


New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Urine Chemistry Control
Dropper Urine Chemistry Control
New
Rapid Test Reader
DIA5000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The study showed tailored doses cut severe side effects (Photo courtesy of 123RF)

Genetic Testing Reduces Chemotherapy Risks for Gastrointestinal Cancer Patients

For patients with gastrointestinal cancers such as colorectal and pancreatic cancer, standard chemotherapy doses can trigger severe and sometimes life-threatening side effects in those carrying specific... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: Insights into sarcomatoid renal cell carcinoma point to broader use of common immunotherapies (Photo courtesy of Salgia NJ et al., Cancer Cell, 2025)

Novel Gene Signature Predicts Immunotherapy Response in Advanced Kidney Cancers

Sarcomatoid renal cell carcinoma (sRCC) is a rare, aggressive form of kidney cancer comprising about 5% of cases and is typically diagnosed at late stages. Resistant to most therapies, it has shown unusually... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.